Trial to Assess the Safety and Effectiveness of the SYNERGYTM Stent System for the Treatment of Atherosclerotic Lesion(s)

What we are studying

The purpose of this research study is to compare the safety and effectiveness of two drug-eluting stents in the treatment of coronary artery disease: the SYNERGYTM Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGY stent) and the PROMUS Elementâ„¢ Plus Everolimus Eluting Platinum Chromium Coronary Stent System (PROMUS Element Plus stent).

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • At least 18 years of age
  • Eligible for percutaneous coronary intervention (PCI)
  • Symptomatic coronary artery disease
  • Candidate for coronary artery bypass grafting (CABG)

What is involved

  • Random assignment to treatment group
  • Screening visits and tests
  • Placement of coronary stent
  • Medication therapy after surgery
  • 3 in person follow-up visits
  • 5 phone follow-up visits

Compensation

No payment will be made to you for your participation in this study. However reasonable travel expenses up to $50, outside your hospital visits that are part of your routine care, will be paid when visits are completed in the office.

Contact Information

Study Coordinator
Teresa Young
Email
tyoung@wakehealth.edu
Phone
Not Listed

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.